We are camphorsulfonic acid CAS:3144-16-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests
Chemical Name: camphorsulfonic acid
CAS.NO: 3144-16-9
Synonyms:
camphersulfosaeure
10-Camphorsulfonic acid
Bicyclo[2.2.1]heptane-1-methanesulfonic acid, 7,7-dimethyl-2-oxo-, (1S)-
(1S)-(+)-10-Camphors
D-CAMPHORSULPHONIC ACID
D(+)-10-Camphorsulfonic acid
((1S,4R)-7,7-Dimethyl-2-oxobicyclo-[2.2.1]heptan-1-yl)methanesulfonic acid
((1S,4R)-7,7-Dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonic acid
(+)-Camphor-10-sulfonic acid (β)
D-(+)-10-Camphorsulfonic Acid
Molecular Formula: C10H16O4S
Molecular Weight: 232.29700
Physical and Chemical Properties:
Density: 1.331g/cm3
Boiling point:/
Melting point: 195ºC
Flash point:/
Refractive index: 1.540
Specification:
Appearance: White to off-white Crystalline Powder
Purity:≥99%
Loss on drying:<2.5%
Sulfate ash:<0.2%
Ferric iron:<30ppm
Packing:
25kg cardboard drum or according to customer specified requirements
Storage: Sealed in a cool and dry environment at 2-8 ºC.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:
Intermediates of Clopidogrel sulfate CAS:120202-66-6
Intermediates of Clopidogrel CAS:113665-84-2
Intermediates of Clopidogrel camphorsulfonate CAS:120202-68-8
Related News: Domestic API companies cooperate with major international companies through commissioned processing, patent transfer, and joint venture production.(1R,2S)-1-Amino-N-(cyclopropylsulfonyl)-2-ethenylcyclopropanecarboxamide 4-methylbenzenesulfonate CAS:1028252-16-5 The first is the API – which is the central ingredient.1191-41-9 Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.5- (2-fluorofenil) -1H-pirrol-3-carbonitrilo CAS:1240948-77-9 Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely.The downstream industry of the pharmaceutical intermediate industry is mainly the production of APIs, and the relationship between APIs and preparations is in the upstream and downstream industry chain. The consumer demand for downstream preparations will directly affect the demand for APIs.
Product Name | |
---|---|
ethyl N-cyano-N-methylcarbamate | View Details |
1,3-Bis(2,4-Diaminophenoxy)Propane 4HCl | View Details |
2-Chloromethyl-3,4-dimethoxypyridinium Chloride Cas:72830-09-2 | View Details |